ICL Group (NYSE:ICL) 주식

ICL Group

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

NYSE

Equities

Markets

ETFs

ADRT

ARGT

BSAC

DFEN

DXYZ

GOLD

JCPB

NUSI

UPRO

XPER

뉴욕 증권 거래소(NYSE)의 여러 주식들은 기술적 문제로 인해 월요일 동부 표준시 오전 9시 40분 이후 갑자기 거래가 중단되었다. 이번 예상치 못한 거래 중단은 일반적으로 단일 주식의 과도한 변동성을 억제하는 데 사용되는 &#34;상향 한도(Limit Up)/하향 한도(Limit Down)&#34; 코드로 분류된 기술적 문제로 인해 촉발되었다.

버크셔 해서웨이, 치폴레 등 뉴욕 증권 거래소 기술적 문제로 일시 거래 중단 발생

ICL Group Ltd

INTERCLOUD SYSTEMS by InterCloud Systems, Inc.

InterCloud Systems Inc

iShares Global Clean Energy ETF

Invesco Actively Managed Exchange-Traded Fund Trus Invesco AAA CLO Floating Rate Note ETF

Icon PLC

GreenFirst Forest Products Inc

GREENFIRST FOREST PRD NEW by GreenFirst Forest Products Inc. NEW

Evogene Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGN#NASDAQ">EVGN</a>) stock rallied over 20% on Monday following the <a href="https://www.benzinga.com/topic/mergers-and-acquisitions">announcement of an acquisition</a>.
What Happened: The Israel-based company <a href="https://www.benzinga.com/pressreleases/25/04/n44893783/icl-to-acquire-the-activity-of-evogenes-subsidiary-lavie-bio" target="_blank" rel="noreferrer noopener">agreed</a> to sell a majority of Lavie Bio Ltd., its subsidiary, to ICL. 
Terms of the deal remain undisclosed.
ICL will also gain control of Evogene&#8217;s MicroBoost AI for AG platform.
This strategic acquisition strengthens ICL&#8217;s position in the ag-biologicals sector. Lavie Bio will continue its operations within ICL&#8217;s expanded structure. 
Key assets to be transferred to ICL include Lavie Bio&#8217;s core team, technology platform, microbial bank, and commercial products.
See Also: <a href="https://editorial.benzinga.com/wp-admin/post.php?post=879284&amp;action=edit">Gold Rallies To Record, Dollar Drops &#8211; Global Markets Today While US Slept</a>
Why It Matters: The transaction builds on more than two years of collaboration between ICL and Lavie Bio, focused on developing innovative bio-stimulant solutions for agriculture.
&#8220;We believe this transaction unlocks significant value for Evogene&#8217;s shareholders,&#8221; said Ofer Haviv, CEO of Evogene. &#8220;Integrating Lavie Bio into ICL will accelerate progress in the global ag-biologicals market, driving innovation in agriculture.&#8221;
Price Action: EVGN shares are trading higher by 24.74% at $1.21 premarket Monday.
At last check, it was trading higher by almost 20.5%. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44896834/dollar-hits-3-year-lows-us-stocks-tumble-as-trump-threatens-to-fire-powell-contrarians-of-the-world-unite">Dollar Hits 3-Year Lows, US Stocks Tumble As Trump Threatens To Fire Powell: &#8216;Contrarians Of The World, Unite!&#8217;</a></li>
</ul>

News

BASFY

EVGN

THRY

Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI

Barclays analyst Benjamin Theurer maintains ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) with a Equal-Weight and raises the price target from $6 to $7.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on ICL Group, Raises Price Target to $7

BMO Capital analyst Joel Jackson maintains ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) with a Market Perform and raises the price target from $6 to $6.5.

BMO Capital Maintains Market Perform on ICL Group, Raises Price Target to $6.5

WIIM

ICL Group shares are trading lower after reporting Q4 sales below estimates.

Earnings

AAOI

ABEV

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARIS

ARKO

ASTE

ATEC

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is a 20 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $1.60 billion which missed the analyst consensus estimate of $1.65 billion by 3.17 percent. This is a 5.27 percent decrease over sales of $1.69 billion the same period last year.

Earnings Misses

ICL Group Q4 2024 Adj. EPS $0.08, Inline, Sales $1.60B Miss $1.65B Estimate

Shares of fertilizer and potash stocks are trading higher on reports suggesting potash supplier Belaruskali cut production

Barclays analyst Benjamin Theurer upgrades ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) from Underweight to Equal-Weight and raises the price target from $4 to $6.

Upgrades

Barclays Upgrades ICL Group to Equal-Weight, Raises Price Target to $6

Company continues to expand global presence in battery materials space
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.icl-group.com%2F&amp;esheet=54181805&amp;newsitemid=20250116261144&amp;lan=en-US&amp;anchor=ICL&amp;index=1&amp;md5=20d38fb8e438f5aeb23fc33cf78eabdb">ICL</a> (NYSE:<a href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, today announced it has signed a joint venture (JV) agreement with <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fdynanonic.com%2Fenindex.aspx&amp;esheet=54181805&amp;newsitemid=20250116261144&amp;lan=en-US&amp;anchor=Shenzhen+Dynanonic+Co.%2C+Ltd.&amp;index=2&amp;md5=245fb7628f2460dace062849ee85d2e2">Shenzhen Dynanonic Co., Ltd.</a> to establish lithium iron phosphate (LFP) cathode active material (CAM) production in Europe, with an initial investment of approximately &euro;285 million. A new facility at ICL&#39;s Sallent, Spain, site is currently in planning stages and will substantially expand the company&#39;s battery materials business. The project demonstrates ICL&#39;s commitment to developing high-quality solutions for a sustainable supply chain and represents a significant step forward for the company&#39;s battery materials portfolio, this time into Europe.

Contracts

ICL Expands Joint Venture With Shenzhen Dynanonic With Additional Investment Of €285 Million For European LFP Cathode Material Production

ICL Appoints Elad Aharonson As President And CEO, Effective March 13, 2025

Management

General

ICL Announced That Raviv Zoller, The Company's President And CEO For The Past Seven Years, Is Expected To Leave In Early 2025, Following The Appointment Of A Replacement And A Formal Transition

ICL Group shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results and raised its FY24 specialties-driven EBITDA guidance.

<h3>Companies Reporting Before The Bell</h3>
• Global Ship Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) is projected to report quarterly earnings at $2.41 per share on revenue of $174.31 million. 
• Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $246.09 million. 
• Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $4.46 billion. 
• ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $2.03 billion. 
• Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $110.77 million. 
• Strawberry Fields REIT (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STRW#AMEX">STRW</a>) is estimated to report earnings for its third quarter. 
• Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) is projected to report quarterly earnings at $0.38 per share on revenue of $140.07 million. 
• Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) is projected to report quarterly loss at $1.28 per share on revenue of $2.36 million. 
• GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) is estimated to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
• Grab Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) is expected to report quarterly loss at $0.01 per share on revenue of $691.80 million. 
• Ispire Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPR#NASDAQ">ISPR</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $52.81 million. 
• Talos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $500.03 million. 
• Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) is estimated to report earnings for its third quarter. 
• Mineralys Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) is expected to report earnings for its third quarter. 
• Live Nation Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) is likely to report quarterly earnings at $1.71 per share on revenue of $8.09 billion. 
• Gatos Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATO#NYSE">GATO</a>) is projected to report earnings for its third quarter. 
• Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) is likely to report earnings for its third quarter. 
• Archrock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $283.55 million. 
• Ampco-Pittsburgh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AP#NYSE">AP</a>) is likely to report earnings for its third quarter. 
• FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $30.69 million. 
• Bioceres Crop Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOX#NASDAQ">BIOX</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $120.80 million. 
• RMR Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMR#NASDAQ">RMR</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $220.35 million. 
• Assertio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASRT#NASDAQ">ASRT</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $28.87 million. 
• Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) is projected to report quarterly loss at $0.28 per share on revenue of $1.04 million. 
• Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $57.50 million. 
• Aterian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) is expected to report quarterly loss at $0.55 per share on revenue of $26.01 million. 
• QuickLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUIK#NASDAQ">QUIK</a>) is likely to report quarterly loss at $0.05 per share on revenue of $4.20 million. 
• VAALCO Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGY#NYSE">EGY</a>) is estimated to report quarterly earnings at $0.17 per share on revenue of $145.89 million. 
• Assured Guaranty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGO#NYSE">AGO</a>) is projected to report quarterly earnings at $1.36 per share on revenue of $201.37 million. 
• Stereotaxis (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STXS#AMEX">STXS</a>) is likely to report quarterly loss at $0.05 per share on revenue of $7.10 million. 
• NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $3.00 million. 
• Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) is expected to report quarterly loss at $0.17 per share on revenue of $18.68 million. 
• James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $146.56 million. 
• Crescent Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCAP#NASDAQ">CCAP</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $48.69 million. 
• IAC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) is estimated to report quarterly loss at $0.28 per share on revenue of $923.69 million. 
• Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $298.54 million. 
• Intevac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVAC#NASDAQ">IVAC</a>) is expected to report quarterly loss at $0.15 per share on revenue of $11.50 million. 
• Nevro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVRO#NYSE">NVRO</a>) is likely to report quarterly loss at $0.81 per share on revenue of $93.07 million. 
• Zeta Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $248.65 million. 
• DoubleDown Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDI#NASDAQ">DDI</a>) is estimated to report quarterly earnings at $0.55 per share on revenue of $85.43 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANGI

ARMK

AROC

ASRT

ATER

BAER

BIOX

CCAP

GATO

GRAB

ISPR

IVAC

JRVR

LAZR

LINC

MLYS

MNDY

NPWR

NUWE

NVRO

QUIK

SPNS

STRW

STXS

TALO

TISI

XAIR

YALA

ZETA

Earnings Scheduled For November 11, 2024

The company raised its guidance for full year 2024 and now expects specialties-driven EBITDA of between $0.95 billion to $1.05 billion, an increase from previous guidance of $0.8 billion to $1.0 billion. The company intends to limit its total 2024 annual potash sales volumes to 4.6 million metric tons, already committed, which is in-line with 2023 sales volumes and in expectation of improved conditions in 2025.

Guidance

ICL Raised Its FY24 Guidance For Specialties-Driven EBITDA To $0.95B-$1.05B From $0.8B-$1B

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.08 by 37.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.753 billion which missed the analyst consensus estimate of $1.788 billion by 1.98 percent. This is a 5.85 percent decrease over sales of $1.862 billion the same period last year.

Earnings Beats

ICL Group Q3 2024 Adj. EPS $0.11 Beats $0.08 Estimate, Sales $1.753B Miss $1.788B Estimate

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) is preparing to release its quarterly earnings on Monday, 2024-11-11. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect ICL Group to report an earnings per share (EPS) of $0.09.
Anticipation surrounds ICL Group's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings History Snapshot</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 0.95% increase in the share price the next day.
Here's a look at ICL Group's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.08</td>
<td>0.09</td>
<td>0.08</td>
<td>0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.10</td>
<td>0.09</td>
<td>0.10</td>
<td>0.11</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>4.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1731074516_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of ICL Group were trading at $4.23 as of November 07. Over the last 52-week period, shares are down 10.0%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/ICL/earnings">To track all earnings releases for ICL Group visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ICL Group's Earnings: A Preview

Company signs MOU to supply key component for production of LiPF6 battery materials
ICL (NYSE:<a href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, today announced it has signed a memorandum of understanding (MOU) with Orbia Advance Corp., S.A.B. de C.V. (BMV:<a class="ticker" href="https://www.benzinga.com/stock/ORBIA#BMV">ORBIA</a>) Fluor &amp; Energy Materials (OF&amp;EM), as both companies continue to expand their presence in the North American battery materials supply chain. The MOU provides a framework for ICL's Industrial Products division to supply phosphorus trichloride (PCl3) to OF&amp;EM for its use in the production of LiPF6 – a critical raw material for lithium-ion batteries – at its planned St. Gabriel, La., manufacturing plant. ICL produces PCl3 at its plants in Gallipolis Ferry, W.Va., and in Bitterfeld, Germany, and is considered a leading global supplier of this high-quality material necessary for this essential battery component.
This partnership allows ICL and OF&amp;EM to work together to advance electrification for both transportation and stationary applications and to bring the production of this critical component to North America. It will also enable them to optimize the performance, efficiency and safety of batteries used in consumer electronics, energy storage and other applications.

BMV:ORBIA

ICL Announced It Has Signed A MoU With Orbia Advance Corp., S.A.B. de C.V. Fluor & Energy Materials, As Both Companies Continue To Expand Their Presence In The North American Battery Materials Supply Chain

Biotech

SeaStar Medical Reports Strong Enrollment Progress In Pivotal Adult AKI Trial With 46 Total Subjects Enrolled; Trial Evaluates Safety And Efficacy Of Selective Cytopheretic Device For Acute Kidney Injury Patients In ICU

ICL Expands In China With New Food Specialty Plant In Zhangjiagang Free Trade Zone, Focuses On Innovative Solutions For Meat, Poultry, And Seafood Segments

Growing Solutions signs agreement with AMP Holdings Group for specialty water soluble fertilizers
ICL (NYSE:<a href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, today announced it has signed a five-year agreement with AMP Holdings Group Co. Ltd., one of China's top agricultural distribution companies. The agreement, valued at approximately $170 million, will run until 2028 and advances ICL's stated goal to expand its Growing Solutions product offerings and to position the business for further growth in major end-markets.
The agreement is for specialty water soluble fertilizers, which are used in drip irrigation and designed for cash-crops, such as apples, watermelons, vegetables, strawberries, ginger and grapes. It includes a minimum purchase commitment, with certain exclusivity conditions based on brand and region.

ICL Signed A 5-Year Agreement With AMP Holdings Group Co, Continues Global Specialty Fertilizers Expansion With ~$170M Distribution Agreement In China

Press Releases

ICL Announces Follow-On Investment in Plantible Foods and Celebrates Industry Recognition for Innovative Food Ingredient

ICL Announces Appointment of Elad Aharonson as New President and Chief Executive Officer

ICL Signs Strategic Agreement with Dynanonic to Produce Lithium Iron Phosphate for European Battery Market

ICL Announces Fourth Quarter 2024 Earnings Call

GROWERS Revolutionizes Agriculture Loyalty Program Through Use of AI

ICL to Participate in Fireside Chat at Bank of America 2025 Global Agriculture and Materials Conference

Comments

ICL Group

뉴스

파트너 / 기고자

벤징가 글로벌